Követés
Mohamed Mashal, B.Pharm, MSc, PhD.
Mohamed Mashal, B.Pharm, MSc, PhD.
E-mail megerősítve itt: ikasle.ehu.eus
Cím
Hivatkozott rá
Hivatkozott rá
Év
A novel cationic niosome formulation for gene delivery to the retina
G Puras, M Mashal, J Zárate, M Agirre, E Ojeda, S Grijalvo, R Eritja, ...
Journal of Controlled Release 174, 27-36, 2014
1292014
Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60
M Mashal, N Attia, G Puras, G Martínez-Navarrete, E Fernández, ...
Journal of controlled release 254, 55-64, 2017
472017
Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery
S Grijalvo, G Puras, J Zárate, M Sainz-Ramos, NAL Qtaish, T López, ...
Pharmaceutics 11 (2), 50, 2019
452019
Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration
N Attia, M Mashal, S Grijalvo, R Eritja, J Zárate, G Puras, JL Pedraz
Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 521-531, 2018
372018
Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: the role of protamine
G Puras, G Martínez-Navarrete, M Mashal, J Zarate, M Agirre, E Ojeda, ...
Molecular Pharmaceutics 12 (10), 3658-3671, 2015
352015
Gene delivery to the rat retina by non-viral vectors based on chloroquine-containing cationic niosomes
M Mashal, N Attia, G Martínez-Navarrete, C Soto-Sánchez, E Fernández, ...
Journal of Controlled Release 304, 181-190, 2019
312019
Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain
M Mashal, N Attia, C Soto-Sánchez, G Martínez-Navarrete, E Fernández, ...
International journal of pharmaceutics 552 (1-2), 48-55, 2018
252018
Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes
E Ojeda, M Agirre, I Villate-Beitia, M Mashal, G Puras, J Zarate, JL Pedraz
Non-Viral Gene Delivery Vectors, 63-75, 2016
152016
Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles
N Attia, M Mashal, C Soto-Sánchez, G Martinez-Navarrete, E Fernández, ...
Drug design, development and therapy 12, 3937, 2018
122018
Mesenchymal stem cells: the past present and future
N Attia, M Mashal
Cell Biology and Translational Medicine, Volume 11, 107-129, 2020
102020
Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro
N Attia, M Mashal, S Grijalvo, R Eritja, G Puras, JL Pedraz
Journal of Drug Delivery Science and Technology 53, 101219, 2019
72019
Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects
N Attia, M Mashal, G Puras, JL Pedraz
Pharmaceutics 13 (6), 843, 2021
52021
Mesenchymal stem cells versus their extracellular vesicles in treatment of liver fibrosis: Is it possible to compare?
N Attia, YH Khalifa, DM Rostom, M Mashal
Medical Research Archives 9 (2), 2021
32021
Insights into the potential role of alpha1‐antitrypsin in COVID‐19 patients: Mechanisms, current update, and future perspectives
S Marzouk, N Attia, M Mashal
The Clinical Respiratory Journal 15 (9), 1019-1024, 2021
22021
The use of cerium oxide nanoparticles in liver disorders: A double‐sided coin?
N Attia, DM Rostom, M Mashal
Basic & Clinical Pharmacology & Toxicology 130 (3), 349-363, 2022
12022
Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
N Attia, M Mashal, S Pemminati, A Omole, C Edmondson, W Jones, ...
Cells 11 (1), 116, 2021
12021
Design, elaboration, characterization and evaluation of niosome formulations for gene delivery to retina and brain
MAA Mashal
Universidad del País Vasco-Euskal Herriko Unibertsitatea, 2020
2020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–17